Correlation Between Acrivon Therapeutics, and Catalyst Biosciences
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Catalyst Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Catalyst Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Catalyst Biosciences, you can compare the effects of market volatilities on Acrivon Therapeutics, and Catalyst Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Catalyst Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Catalyst Biosciences.
Diversification Opportunities for Acrivon Therapeutics, and Catalyst Biosciences
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Acrivon and Catalyst is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Catalyst Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Biosciences and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Catalyst Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Biosciences has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Catalyst Biosciences go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Catalyst Biosciences
Given the investment horizon of 90 days Acrivon Therapeutics, is expected to generate 3.96 times less return on investment than Catalyst Biosciences. In addition to that, Acrivon Therapeutics, is 1.06 times more volatile than Catalyst Biosciences. It trades about 0.01 of its total potential returns per unit of risk. Catalyst Biosciences is currently generating about 0.06 per unit of volatility. If you would invest 32.00 in Catalyst Biosciences on August 29, 2024 and sell it today you would earn a total of 9.00 from holding Catalyst Biosciences or generate 28.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.52% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Catalyst Biosciences
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Catalyst Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acrivon Therapeutics, and Catalyst Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Catalyst Biosciences
The main advantage of trading using opposite Acrivon Therapeutics, and Catalyst Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Catalyst Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will offset losses from the drop in Catalyst Biosciences' long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals | Acrivon Therapeutics, vs. Seres Therapeutics |
| Catalyst Biosciences vs. Akari Therapeutics PLC | Catalyst Biosciences vs. Benitec Biopharma Ltd | Catalyst Biosciences vs. Pulmatrix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |